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INVESTIGATION OF PLURIPOTENT STEM CELLS IN HUMAN 
DENTAL FOLLICLE
SUMMARY
Stem cells hold promises for many people suffering from Parkinson, Alzheimer, 
Diabetes, spinal injuries and even cancer. It is quite important to find an ideal stem 
cell source to develop therapeutic applications for these diseases. Embryonic stem 
cells are classified as pluripotent stem cells since they have unique capacity to
differentiate into various tissues and organs, offering replacement of damaged or 
non-functional tissues with new ones. Embryonic stem cells are characterized 
according to their morphology, surface markers, and expressions of 
developmentally regulated proteins such as, Oct-4, Sox-2, Klf-4...etc. As the 
isolation of embryonic stem cells requires killing of embryos, it gives rise to 
controversies all over the world. In addition to this, it is also difficult and expensive 
to maintain embryonic stem cells cultures as they require some special conditions. 
On the other hand, stem cells derived from other sources such as umbilical cold 
blood, bone marrow, adipose tissue, dental pulp, etc., seem to be much more easily 
obtainable and ethically harmless. Adult stem cells are not pluripotent because they 
cannot give rise to all mature cells types coming from three different germ layers, 
ectoderm, mesoderm, and endoderm. They generally do differentiate into the cell 
type of the tissue where they reside. Recent studies showed that adult stem cells
can differentiate into some other cells types if they are induced specifically, which is 
called as transdifferentiation or plasticity. For example, a Hematopoietic Stem Cell 
(derived from bone marrow) can give rise to a neuron or a hepatocyte instead of a 
leukocyte or erythrocyte. For this reason adult stem cells are also called as
multipotent stem cells.
xTo achieve effective use of stem cells in clinics, it is necessary to find easily and 
less expensively obtainable and well characterized stem cell sources. So far,
although bone marrow is used as the primary sources of adult stem cells for clinics, 
it brings about a surgical stress and contamination risk. Isolation of stem cells from 
other adult stem cell sources such as dental follicle and dental pulp as a by-product 
of routine treatment might be an advantageous approach over usage of bone 
marrow derived stem cells. 
Stem cells isolated from human dental follicles (HDF) are being investigated to
show their differentiation potential. They have relatively high potential of proliferation
and can differentiate into osteocytes, adipocytes and chondrocytes. Most recent 
data show that human dental follicle cells (HDFCs) might transdifferentiate into 
neurons. 
In this study, HDFCs from a 17 years old patient’s wisdom tooth dental follicle, 
which was extracted because of some orthodontic reasons, were isolated. For the 
first time, it was tried to detect the expressions of some pluripotent stem cells 
markers such as Oct-4 and Nucleostemin (NS) in HDFCs with the aim of identifying 
pluripotent stem cells in dental follicle. Also, in-vitro neurogenic differentiation of 
HDFCs was investigated suggesting, for the first time, a retinoic acid mediated 
neurogenic differentiation model might work in HDFCs.
According to the results, HDFCs contained putative Oct-4 and NS expressing 
pluripotent stem cells in very rare number. In consistency with previous data,
HDFCs can be differentiated into osteogenic and neurogenic cells. Based on this, it 
can be said that our retinoic acid mediated induction is a putative model of 
neurogenic differentiation for HDFCs.
As a conclusion, it can be suggested that HDFCs can be a valuable stem cell 
source for autologous transplantation which does not provoke immune rejection 
upon transplantation. Dental follicles might be collected after routine extractions of 
wisdom teeth and stored in liquid nitrogen as a readily available stem cell source for 
the future.
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İNSAN DENTAL FOLİKÜLÜNDEKİ PLURİPOTENT KÖK 
HÜCRELERİN ARAŞTIRILMASI     
ÖZET
Kök hücreler, Alzhimer, Parkinson, diyabet, omirilik yaralanması ve hatta kanser 
hastaları için bir ümit kaynağı olmaya devam etmektedir. Bu hastalıkların 
tedavisinde kullanılabilinecek kök hücre tedavileri geliştirebilmek için en ideal 
özelliklere sahip kök hücrelerin elde edilmesi zorunludur. Embriyonik kök hücreler
vücuttaki tüm hücre tiplerine farklılaşabildikleri için “pluripotent” olarak adlandırılırlar. 
Embriyonik kök hücreler yüksek farklılaşma potensiyellerinin yanı sıra yüzey 
antijenleri, morfolojileri ve gelişimsel olarak sentezledikleri Oct-4, Sox-2, Klf-4, vb, 
farklı proteinlerin varlığına bağlı olarak karekterize edilirler. Embriyonik kök hücre 
izolasyonu canlı embriyoların feda edimesini gerektirdiği için bu konu ile ilgili etik 
sorunlar dünyanın her yerinde tartışılmaktadır. Öte yandan, embriyonik kök 
hücrelerin kültürde çoğaltıması pahalı, zahmetli ve özel koşulların sağlanmasını 
gerektiren bir yöntemdir.
Kordon kanı, kemik iliği, yağ dokusu, diş pulpası vs, gibi kaynaklardan elde edilen 
kök hücreler, embriyonik kök hücrelere nisbeten etik açıdan daha az sorunlu olup, 
kolayca kültürde çoğaltılabilir ve genel olarak yetişkin kök hücreler olarak 
adlandırılırlar. Yetişkin kök hücreler pluripotent değildir. Çünkü ektoderm, 
mezoderm ve endoderm’den gelen tüm hücre tiplerine farklılaşma potansiyelleri 
yoktur. Yetişkin kök hücreler daha çok bulunduğu dokudaki hücrelere farklılaşırlar. 
Ancak yapılan son çalışmalar yetişkin kök hücrelerin çapraz farklılaşma
(transdifferansiasyon) ya da plastisite gösterebildiklerini ortaya koymuştur. Örneğin
bir kemik iliği kök hücresinin lökosit ve eritrosite dönüşmesi beklenirken, uygun 
ortamlar sağlandığında sinir ya da karaciğer hücresine dönüşebilmesi mümkündür.
Bu sebepten, yetişkin kök hücreler için multipotent tanımı kullanılmaktadır.
xii
Kök hücrelerin klinikte tedavi amacıyla başarılı bir şekilde kullanılabilmeleri için 
kolay ve ucuz bir şekilde elde edilip tamamen karakterize edilmeleri gerekmektedir. 
Günümüzde her ne kadar kemik iliği klinikte kullanılan kök hücrelerin ana kaynağı 
olsa da, beraberinde cerrahi stres ve kontaminasyon riskini getirmektedir. Bu 
noktalar dikkate alındığı zaman, kök hücrelerin, diş folikülü ya da diş pulpasından 
rutin tedaviler sırasında açığa çıkan atık dokulardan elde edilmesi kemik iliğinden
elde edilmesinden daha avantajlı görülmektedir.
Dental folikülden elde edilen kök hücrelerin karakterizasyonu ve farklılaşma 
potansiyeli ile ilgili çalışmalar devam etmektedir. Çalışmalar dental folikülden elde 
edilen hücrelerin, kemik, kıkırdak ve yağ dokusuna kolayca farklılaşabileceğini 
göstermiştir. Ayrıca, son zamanlarda bazı gruplar dental folikül kök hücrelerini sinir 
hücrelerine benzeyen hücrelere farklılaştırdıklarını açıklamışlardır. 
Bu çalışmada 17 yaşında bir hastaya ait olan üçüncü molar diş folikülünden (yirmi 
yaş dişi) dental folikül hücreleri elde edilmiştir. Folikül, hastanın rutin devam eden 
tedavisinde hekimin gerekli görüp folikülü çıkarması sonucu elde edilmiştir. Bu 
çalışmada dental folikül hücrelerinin pluripotent hücre içerip içermediğini anlamak 
amacıyla, ilk defa üzerlerinde plurioptent kök hücre markeri olan Oct-4 ve NS 
(Nucleostemin) birlikte tespit edilmeye çalışılmıştır. Buna ek olarak dental folikül 
hücrelerinden ilk defa retinoik asit içeren bir yöntem kullanarak sinir hücrelerine 
benzeyen hücreler elde edilmesi amaçlanmıştır.
Çalışmanın sonunda, daha önce yapılan çalışmalar ile paralel olarak insan dental 
folikül hücrelerinden kemik hücresi  ve sinir hücresi benzeri hücreler elde edilmiştir. 
Ayrıca çalışmada elde edilen sonuçlara göre, yirmi yaş dişi folikülünden elde edilen 
kök hücreler arasında çok az miktarda da olsa Oct-4 ekspresyonu yapan hücreler 
bulunmaktadır. Sinirsel farklılaşmada başarılı olunması retinoik asit aracılı bir 
sinirsel farklılaşmanın insan dental folikül hücrelerinde aktif olabileceğini 
göstermektedir.
xiii
Sonuç olarak yapılan çalışma, insan dental folikülü kök hücrelerinin kolay elde 
edilebilir ve kişiye özel otolog transplatasyon için çok uygun bir kaynak olabileceği 
tezini desteklemektedir. Öyleyse, rutin yirmiyaş dişi çekimlerinde atık olarak açığa 
çıkan foliküllerden kişiye ait kök hücrelerin izole edilip depolanması, kişinin ileride 
ihtiyaç duyabileceği kök hücre kaynağını oluşturabilme potansiyeli açısından
oldukça önem kazanmaktadır.
11. INTRODUCTION
1.1Stem Cells
The present excitement and controversies about stem cell research began with two 
breakthroughs: (i) successful cloning of “Dolly” by Ian Wilmut, Keith Campbell and 
coworkers in 1997; and (ii) the establishment of human embryonic stem cell (ESC) 
lines by the laboratory of James Thomson in 1998 (Ho A.D. et al.,2003). Today 
stem cell research gives hope that a lot of age related degenerative disorders such 
as heart disease, Parkinson’s disease, diabetes, and stroke could someday be 
cured by stem cell therapy.
Stem cells are unspecialized cells in the human body that are capable of becoming 
specialized cells, each with new specialized cell functions. The most well known 
example of stem cell is the bone marrow stem cells that are unspecialized and able 
to differentiate into blood cells, such as white and red blood cells. These new cell 
types have special functions, such as being able to produce antibodies, act as 
soldiers to combat infection and transport gases. Bone marrow transplantation is 
actually the transfer of these stem cells into donors having immune system 
problems. This “Stem cell” term is used as one cell type stems from the other.
Basically, a stem cell remains uncommitted until it receives a signal to develop into 
a specialized cell. Apart from blood cells, stem cells have the remarkable properties 
of developing into a variety of cell types in the human body. They serve as a repair 
system by dividing without limitation to replenish other cells. When a stem cell 
divides, each new cell has the potential to either remain as a stem cell or become 
another cell type with new special functions, such as blood cells, brain cells, etc
(Bongso and Lee, 2005). 
During embryogenesis, one fertilized egg cell – the zygote – becomes two, and two 
become four. In these early stages, each cell is called totipotent – that is, a whole 
organism can be derived out of each of these cells. Within 5 to 7 days, blastocyst is 
formed by around 40 cells consist of the inner cell mass and surrounding cells 
2called trophoblasts. At this stage, each of these cells in the inner cell mass has the 
potential to give rise to all tissue types and organs including germ cells – that is, 
these cells are pluripotent (Figure 1.1). Ultimately, the cells forming the inner cell 
mass will give rise to the trillions of cells that constitute a human body, organized in 
200 differentiated cell types. Many somatic, tissue-specific or adult stem cells are 
produced during fetal development. Such stem cells have more limited ability than 
the pluripotent embryonic stem cells (ESC) and they are called multipotent. These 
cells have the ability to give rise to multiple lineages of cells. These adult stem cells 
persist in the corresponding organs to varying degrees during a person’s whole 
lifetime.
Figure 1.1: Sources of stem cells (Ho A.D. et al.,2003)
A stem cell can either remain a stem cell, that is called self-renewal, or follow a 
pathway resulting in differentiation. In differentiation pathway, daughter becomes 
a precursor cell which proliferates before it differentiates. Progenitor cell term is 
usually used instead of precursor term but some attribute progenitor cell to the 
cells with greater developmental potential than a precursor cell (Raff, 2003). 
Precursor cells within a tissue start to proliferate and finally differentiate upon an 
3injury, for example to restore damaged tissue.  Although factors determining 
whether a stem cell remains a stem cell or undergoes differentiation are not clear, 
today we know that cell-fate determinants from the mother cell and environmental 
factors are playing important roles.
    
1.2 Classification and Sources of stem cells 
Stem cells can be classified into four broad groups on the basis of their origin. 
These are embryonic stem cells (ESCs) from embryos; fetal stem cells (FSCs)
from the fetus; umbilical cord blood stem cells (UCBSCs) from the umbilical 
cord; and adult stem cells from the adult (Bongso and Lee, 2005). Each of these 
can be grouped into subtypes (Figure 1.2). 
Figure 1.2: Types of stem cells (Bongso and Lee, 2005)
41.2.1. Embriyonic Stem Cells (ESCs)
In mammals, zygote, 2-cell, 4-cell, 8-cell and morula stages contains totipotent  
cells that are able to form a complete organism. Pluripotent Human Embryonic 
Stem Cells (hESCs) are derived from inner cell mass (ICM) of the 5- to 6-day old 
human blastocyst. During embryonic development, the ICM develops into two 
distinct cell layers, the epiblast and hypoblast. The hypoblast forms the yolk sac 
which later becomes redundant in the human, and the epiblast differentiates into the 
three primordial germ layers: ectoderm, mesoderm and endoderm (Figure 1.3).
Human embryonic stem cells (hESCs) can be isolated from: i) surplus embryos left 
over after in vitro fertilization (IVF) treatment; ii) embryos created specifically
for this purpose; and iii) embryos created by somatic cell nuclear transfer. The latter 
two approaches are heavily charged with emotional and ethical implications while 
the first is less controversial.
Figure 1.3: Cell linages from the ICM of human blastocysts (Bongso et. al., 2005)
5All of these approaches bring about some controversies and eventually affects the 
development of stem cell based therapies and its funding. The reason is that 
derivation of ESCs from embryos results in destruction of embryos. For many 
people of faith around the world, an embryo is fully a human being and therefore 
may not be killed (Suzanna et al., 2001). Although millions of people believe that 
hESCs research will improve the quality of their lives, the two major obstacles must 
be overcome, a) hESC culture technology in vitro must receive FDA (Food and 
Drug Administration) approval in USA, and b) enough hESC lines must be 
produced to generate the required number of cells for later clinical application. 
Proponents of embryonic stem cell usage admit that potential treatments include 
risk for both immune rejections by the patient and tumor formation (Jon S Odorico 
et. al., 2001).  ECSs have unique properties that make them preferable among 
other stem cell sources (Table 1.1) but they are difficult and expensive to establish 
and maintain in culture. ESCs need a feeder cell layer to remain undifferentiated 
and continue its growth utilizing the secretions of feeder cells which are cytokines. 
Feeder cell layer also helps ESCs to attach to the cell culture flask. But, this brings 
about some risk of transmission of some infectious agents from feeder cells to 
ESCs. It was reported that embryonic stem cells are genomically unstable, 
exhibiting variable gene expression even in controlled conditions of the laboratory 
(Humpherys et. al., 2001)
Table 1.1: Unique Characteristics of hESCs (Bongso et. al., 2005)
                      
6Certain hESC lines (H7.S6 and H14.S9, University of Wisconsin) showed karyotypic 
changes involving the gain of chromosomes 17q and 12 with extended culture of 22 
to 60 passages (2–6 months) (Draper et. al.2003).  Interestingly, these aneuploid 
karyotypes were very similar to those seen with human embryonic carcinoma cells. 
Especially in feeder free culture conditions, stem cells might show adaptive genetic 
changes (Pera, 2004)
Another important issue is to keep differentiation conditions under control. ECSs 
can differentiate spontaneously. There are three approaches to achieve controlled 
differentiation: 1) Treating the hESCs with specific agents (growth factors, 
chemicals) to generate a specific differentiated cell type e.g. retinoic acid to produce 
neurons; 2) Growing hESCs in direct contact with companion fetal cells of the 
required cell type or a different cell type (co-culture) with the hope that the 
companion cell will release certain factors that will lead the hESCs to be converted 
to the desired cell type; 3) Transfecting specific gene constructs into hESCs and the 
gene then switching on in order to direct the hESCs to differentiate along a specific 
cell pathway, e.g. when the cardiomyosin gene inserted into mESCs and then 
switched on, it converts the mESCs into cardiomyocytes (Bongso et. al., 2005) . 
In order to derive stable hESC lines, the gametes and ensuing embryos must be 
high quality and have no genetic and infectious diseases. Patients donating such 
material must be screened for HIV, hepatitis B, sex-linked and autosomal genetic 
diseases. hESCs must be grown under current good manufacturing practice 
(cGMP) and good tissue culture practice (GCTP) conditions. HLA typing for future 
tissue matching, tests for full characterization (using molecular genetic markers) 
and sustainability in vitro without karyotypic changes for prolonged passages should 
be performed.
  
Another embryo derived stem cell type is embryonic germ cells (EGCs). They are 
actually obtained by culturing Primordial germ cells (PGCs) in vitro. Primordial germ 
cells originate from proximal epiblast and they are the precursors of oogonia and 
prospermatogonia (Pera and Dottori, 2005). Primordial germ cells or diploid germ 
cell precursors transiently exist in the embryo before they closely associate with 
somatic cells of the gonads and then become committed as germ cells. Human 
embryonic germ cells (hEGCs) which are also stem cells are obtained from the 
primordial germ cells of the gonadal ridge of 5- to 9-week old fetuses (Figure 1.4).  
7hEGCs have been successfully isolated and characterized. These stem cells are 
pluripotent and are able to produce cells of all three germ layers, ectoderm 
endoderm and mesoderm. 
Figure 1.4: Primordial germs cells (URL-1)
1.2.2. Fetal Stem Cells
Fetal stem cells are primitive cell types found in the organs of fetuses. Neural crest 
stem cells, fetal hematopoietic stem cells and pancreatic islet progenitors have 
been isolated in abortuses. Human fetal pancreatic cells grow and differentiate after 
transplantation in nude mice (Beattie et. al.,1997). Fetal neural stem cells found in 
the fetal brain were shown to differentiate into both neurons and glial cells (Brustle
et.al. 1998). However, isolation of pluripotent stem cells from fetuses increases
people’s skepticism about its ethical results. During isolation, abortuses is used and 
it is believed by some that this increases the rate of abortions indirectly. But some 
materials which do not require abortion such as fetal blood, placenta and umbilical 
cord can be used as rich sources of fetal hematopoietic stem cells.
Another ethically harmless fetal stem cell source seems to be amniotic fluid. Human 
Amniotic Fluid (HAF) obtained during the process of amniocentesis (Figure 1.5) 
contains a variety of stem cell originated from embryonic and extraembryonic 
tissues (Kim et.al. 2007). It was reported that HAF contains multipotent stem cells 
(Tsai et. al. 2004). In humans, the expansion potential of mesenchymal amniocytes 
exceeds that of bone-marrow-derived mesenchymal stem cells (Fauza, 2004). 
Human amniotic fluid epithelial cells are able to differentiate into neurons, 
8astrocytes and oligodenrocytes, therefore, Human amniotic fluid stem cells 
(HAFSCs) might be a possible candidate for transplantation therapy of 
neurodegenerative diseases (Kakishita et. al. 2003). Unlike their mesenchymal 
counterparts, cells that could be ESCs are very rare in the human amniotic fluid, 
representing 0-1% of the cells. This means ESCs cannot always be isolated from 
the amniotic fluid. In addition, these cells have been identified mostly through 
markers commonly present in ESCs, such as nuclear Oct-4, stem cell factor, 
vimentin, alkaline phosphatase, CD34, CD105, and c-Kit (Figure 1.6). These 
markers can be expressed alone or in various combinations in embryonic germ 
cells; embryonic fibroblasts; embryonal carcinoma cells; mesenchymal stem cells; 
hematopoietic stem cells; ectodermal, neural, and pancreatic progenitor cells; and 
fetal and adult nerve tissues (Fauza, 2004)     
Figure 1.5: Amniocentesis (Fauza, 2004)
The Amniotic fluid mesenchymal stem cells (AFMSCs) can expand rapidly and they 
maintain their capacity to differentiate into multiple cell types in vitro. Aside from the 
common mesenchymal lineages (adipocytes and osteocytes), they also have been 
differentiated successfully into neuron-like cells (Figure 1.6). Most recently it was 
9reported that stem cell derived from amniotic fluid can differentiate into cell types 
representing each embryonic germ layer, including cells of adipogenic, osteogenic, 
myogenic, endothelial, neuronal and hepatic lineages (De Coppi et. al. 2007). Same 
group also showed that when the cells were maintained for over 250 population 
doublings, they retained long telomeres and a normal karyotype.
Figure 1.6: Multipotential stem cells derived from amniotic fluid: a.Osteogenic differentiation 
was shown by von Kossa staining; b. Adipogenic differentiaition was shown by Oil Red O 
staining; c. Positive immunofluorescence stain of β-actin (Tuj-1); d. Immunocytochemical 
staining of Oct-4 positive cells in cultured AFMSCs; (Tsai, 2004) e. AFC A: Cells in Human 
amniotic fluid express Oct-4, Stem cell factor (SCF), vimentin, ALP mRNAs; AFC 
B:Representative sample of Oct-4 negative cells; 18S RNA is an internal standard 
expressed in both type of cells (Prusa et. al.,2003)
1.2.3. Umbilical Cord Stem Cells
Umbilical cord (UC) blood contains circulating stem cells and the cellular contents of 
umbilical cord blood appear to be quite distinct from those of bone marrow and adult 
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peripheral blood. It has been shown that, in contrast to its adult bone marrow (BM) 
counterpart, the stem cell compartment in CB (cord blood) is less mature. This has 
been documented extensively for the hematopoietic system, including a higher 
proliferative potential in vitro as well as in vivo, which is associated with an 
extended life span of the stem cells and longer telomeres (Szilvassy, 2001). The 
frequency of umbilical cord blood hematopoietic stem cells equals or exceeds that 
of bone marrow and they are known to produce large colonies in vitro, have 
different growth factor requirements, have long telomeres and can be expanded in 
long term culture. Cord blood shows decreased graft versus host reaction compared 
with bone marrow, possibly due to high interleukin-10 levels produced by the cells 
and/or decreased expression of the beta-2-microglobulin. Cord blood stem cells 
have been shown to differentiate into osteoblasts, chondrocytes, adipocytes, and 
neural progenitors as well as to differentiate in vivo into bone, cartilage, 
hematopoietic cells, neural, liver, and heart tissue (Figure 1.7) (Kögler, 2005). Since 
UC blood seem to contain mesodermal progenitors for MSCs, and are also an 
easily accessible source of cells, they should be considered as a potential 
candidate for supportive therapy (Kögler, 2005).
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Figure 1.7. Multipotential stem cells derived from UC blood:  A: Differentiation to osteoblasts is shown 
by Alizarin red staining to determine calcium deposition; B: Collagen type II staining to show 
chondrogenic differentiation; C: Oil red-O staining of the lipid vesicles showing adipogenesis; D–F: In-
vitro differentiation of UC blood stem cells into neural cells: Differentiated cells showed positive 
immunoreactivity for the neuron-specific markers neurofilament (D), the enzyme tyrosine hydroxylase 
(E) and DOPA-decarboxylase(F); (G–I) In-vivo differentiation of UC blood stem cells to cardiomyocytes 
and Purkinje fibers: (G) and (H) are serial sections of the right ventricle, (I) A section of a Purkinje fiber. 
Scale bars: (A–E) = 50 mm; (F) = 100 mm; (J, K) In-vivo differentiation of USSC from CB into 
parenchymal liver cells; (L) Anti-human albumin staining of the liver. 
1.2.4. Adult Stem Cells (ASCs)
Somatic stem cell (SSC) and ASC term are being used interchangeably to describe 
stem cells of adult origin. It was thought that adult mammalian stem cells were only 
present in organs such as blood, skin, gut and testis. Today, we know that if not all, 
adult organs contain stem cells. Such ASCs have been known to possess the ability 
to regenerate the corresponding tissue from which they are derived. Adult stem 
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cells usually form only 1-2% of the cell population, their main role is the 
replenishment of the tissue’s cells in appropriate proportions and numbers in 
response to “wear and tear” loss or direct organ damage (Fang et. al., 2004). Adult 
stem and progenitor cells possess the capability of self-renewal and differentiation 
into at least one or more mature cell types. Most adult tissues contain multipotential 
stem cells, i.e. cells that are capable of lifelong renewal and that produce a limited 
range of differentiated cell lineages appropriate to their location (Levicar, 2007).
Such properties make it possible to use adult stem cells to regenerate damaged or 
senescent cells throughout life span of the organism. Based on animal models, 
many studies have recently claimed that ASCs might exhibit developmental 
potentials comparable to those exhibited by ESCs through their having ”plasticity 
potential” or “trans-differentiation” (Figure 1.8) (Wagers et. al., 2002). For example, 
unmanipulated bone marrow cells were found to participate in the muscle 
regeneration process when injected into skeletal muscle (Ferrari, et al. 1998). 
Figure 1.8: Plasticiy of bone marrow derived ASCs (URL-2)
It was reported that bone marrow cells were able to differentiate into microglia, 
astroglia and neurons within the central nervous system (Eglitis and Mezey, 1997). 
Stem cells from the rat bone marrow have been shown to give rise to hepatocytes in
recipients with artificially induced hepatic injury (Peterson et.al.1999).
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1.2.4.1. Hematopoietic stem cells (HSCs)
HSCs are among the few stem cells to be isolated in adult humans. They reside in 
the bone marrow and under some conditions migrate to other tissues through the 
blood. HSCs are also normally found in the fetal liver and spleen and in umbilical 
cord and placenta blood. The ability of hematopoietic stem cells (HSCs) to self-
renew continuously in the marrow and to differentiate into the full complement of cell 
types found in blood makes them as the premier adult stem cells (Figure 1.9)
Figure 1.9: Blood cell differentiation from HSCs (NATIONAL ACADEMY PRESS
2001).
HSCs normally divide to generate either more HSCs (self-renewal) or progenitor 
cells, which are precursors to various blood cell types. HSCs are found mainly in 
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bone marrow, although T cells develop in thymus, and some other cell types 
develop from blood monocytes. Once HSCs partly differentiate into progenitor cells, 
further differentiation into one or a few types of blood cell is irreversible.
Recent studies showed that HSCs have the capacity for transdifferentiation. It was 
shown that HSCs can differentiate into liver cells (Lagasse et. al., 2000), cardiac 
and muscle tissue (Bittner et. al., 1999), and neuron-like cells (Brazelton et. al., 
2000). These findings have raised expectations that HSCs will eventually be shown 
to be able to give rise to multiple cell types from all three germ layers. 
On the other hand, there are some limitations in supplying HSCs for every patient. 
Number of HSCs in bone marrow is rare (one in every 10,000 bone marrow cells) 
and it is difficult to separate them from other components of the blood, thereby bone 
marrow stem cell transplants are generally impure. All cells of the body express on 
their surface a set of molecules called histocompatibility (i.e. tissue compatibility) 
antigens. If a patient receives a transplant of HSC cells from a donor that has 
histocompatibility antigens different from his own, the patient’s body will recognize 
and react to the cells as foreign. To increase success of bone marrow 
transplantation, it is preferred that donors be a related sibling of the transplant 
recipient. In case their histocompatibility antigens do not match, the recipient’s body 
will reject the material or can produce an immune reaction in which the T cells of the
transplant attack the tissues of the recipient’s body, leading to a potentially lethal 
condition known as graft versus host disease. However, autologous transplants, in 
which material from a person is implanted into the same person (for example, when 
a cancer patient deposits his own blood in advance of chemotherapy or irradiation) 
solve the problem of immune system rejection (National Academy Press, 2001). 
Purified and concentrated populations of autologous HSCs transplanted in breast 
cancer patients after chemotherapy have been shown to repopulate the blood more 
swiftly and with fewer complications (Negrin et al., 2000).
1.2.4.2. Mesenchymal Stem Cells (MSCs)
Mesenchymal stem cells (MSCs) are found postnatally in the nonhematopoietic
bone marrow stroma. Marrow stromal tissue is made up of a heterogenous 
population of cells, which include reticular cells, adipocytes, osteogenic cells, 
smooth muscle cells, endothelial cells and macrophages (Bianco and Riminucci,
1998). Apart from bone marrow stroma, MSCs can also be derived from 
periosteum, fat and skin (Figure1.10).
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Figure 1.10: Mesenchymal stem cells (MSCs): MSCs can be isolated from various tissues 
including bone marrow, adipose tissue and umbilical cord blood. MSCs are plastic adherent 
with a spindle-shaped morphology. Adipogenic and osteogenic differentiation can be 
induced by appropriate culture conditions as examined by Oil Red-O staining or von Kossa 
staining. Scale bar: 100 µm (Ho and Wagner, 2005).
MSCs are multipotent cells that are capable of differentiating into cartilage, bone,
muscle, tendon, ligament and fat (Caplan, 1994). There is some recent evidence 
that there is a rare cell within MSC cultures that is pluripotent and can give rise not 
only to mesodermal but also to endodermal tissues (Jiang et. al., 2002). These cells
are also Multipotent Adult Progenitor Cell (MAPCs). MSCs can be expanded in vitro
without losing their “stemness” or self-renewal capacity and they do not need any 
feeder cell layer (Caplan, 2000). To reach desired goals in use of MSCs in clinics, 
many questions must be elucidated. Isolation, propagation and long term culture 
protocols must be universalized. Molecular characterization of MSCs has not still 
been performed completely. Although the reports demonstrated high differentiation
capacity of these cells, exact pathways remains elusive.
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1.3. Human craniofacial stem cells
Human craniofacial stem cells are recently discovered sources of mesenchymal 
stem cells. They represent great promise for autogenic or allogenic transplantation 
and tissue engineering. Prior to employing these cells in clinical applications, they 
must be thoroughly investigated and characterized So far craniofacial stem cells 
were isolated from dental pulp cells (DPCs), dental follicle cells (DFCs), periodontal
ligament cells (PDLCs), and buccal mucosa fibroblasts (BMFs) (Lindroos et. al., 
2008). 
The dental pulp contains connective tissue, mesenchymal stem cells, neural fibers, 
blood vessels, and lymphatics (Figure1.11). Researchers have recognized that 
dental pulp contains ex vivo expandable cells called dental pulp cells. These cells 
express osteogenic markers, such as alkaline phosphatase, type I collagen, bone 
sialoprotein, osteocalcin, osteopontin, transforming growth factor β(TGF-β), and 
bone morphogenetic proteins (BMPs) (Chen et al., 2005). Human DPSCs were 
initially identified on the basis of their traits of forming single colonies in culture, self-
renewal in vivo, and multidifferentiation in vitro (Gronthos et al., 2000).
Figure 1.11: Diagram of a tooth structure (Liu et. al.,2005)
Most recently it has been shown that DPSCs express Oct-4 suggesting that  there 
might be small population of pluripotent stem cells residing in dental pulp. (Huang 
et. al. 2008) (Figure 1.12)
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Figure 1.12: DPSCs express both stem cells and osteogenic markers (Huang et. 
al.2008)
There is also tissue engineering approaches in the maxillofacial region that attempt 
to isolate mesenchymal stem cells from the intraoral sites and utilize these cells for 
therapeutic purposes.  It has been demonstrated that dental follicle cells remain 
stable in terms of transformation and do not undergo differentiation into osteoblast 
and osteocytes in culture (Yao et. al., 2004). The dental follicle surrounds 
developing tooth germ and is an ectomesenchymal derived connective  tissue that 
contains progenitor cells for the development of the periodontium (Figure 1.13).
Figure 1.13: Dental follicle stem cells Dental follicle stem cells give rise to 
peridontium in the presence of growth factors, extra cellular amtrix and cell 
adhesion molecules (Bartold et. al.,2000).
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Morsczeck et. al. (2005) isolated precursor cells from human dental follicle of 
wisdom teeth and suggested that these cells are able to differentiate into PDL-like 
structures. These periodontal ligament stem cells exhibited the capacity to generate 
clonogenic adherent cell colonies when plated under the same growth conditions as 
described for bone marrow stromal stem cells (Seo et. al, 2004). The identification 
of putative mesenchymal stem cell populations within the dental follicle has 
stimulated interest in the potential use of stem cell-based therapies to treat the 
damaged caused by trauma or various diseases.
1.4. Scope of the study
Although bone marrow is a potential cell source for the preparation of MSCs, an 
alternative source of adult stem cells that could be obtained in large quantities with 
minimum surgical stress would be advantageous. Recent evidences has suggested 
that adult stem cells are not exclusive to bone marrow, but are also present in a 
variety of tissues and organs such as liver, nerve, muscle, skin, synovium, cartilage 
and dental tissues. In this study, it was focused on extracted teeth as they are easily 
obtainable waste materials. However, extracted teeth are often decayed, i.e., 
already infected, and present the risk of contamination during cell 
preparation/culturing. Non-decayed third molars including impacted molars are 
sometimes extracted during orthodontic treatment. These third molars, especially 
impacted molars, might be good sources of cells for this purpose because impacted 
molars are generally thought to be free of infection. Impacted third molars from 
young adults (age about 10–16) generally contain immature tissue called tooth 
germ. The tooth germ is a budlike thickening of the dental lamina that is the 
primordium of a tooth. It consists of the dental papilla, the dental follicle, and the 
enamel organ (Ikeda et.al. 2006). Consequently, the dental follicles might be a 
target of interest as a good alternative source of adult stem cells. Although different 
investigations has been conducted on the biological potential of dental follicle cells 
showed that they are highly proliferative and have osteogenic adipogenic and 
chondrogenic differentiation, there is not enough data representing if dental follicles 
contains stem cells expressing pluripotent stem cells markers such as Oct-4 and 
Nucleostemin (NS). It is also little known about transdifferentiation capacity of dental 
follicle derived stem cells. 
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Oct-4 is a very important protein for maintenance of pluripotency of stem cells. It 
activates or represses patterns of gene expression that mediates cellular events 
during differentiation. Oct-4 is a key regulator of stem cell pluripotency and 
differentiation (Pan et.al. 2002). Investigation of adult tissues for the presence of 
Oct-4 expressing cells might be very important for finding new sources for stem cell-
based therapies. NS is expressed by bone marrow derived stem cells. It has been 
shown that NS involves in regulation of telomerase activity thus, it controls 
proliferation of dividing cells (Zhu et. al., 2006). NS is stably expressed in 
proliferating cells. Expression of NS increased when the cells were induced to 
proliferate with FGF-2 (Kafienah, 2006). Therefore, NS expression might correlate 
with proliferation capacity of the cells. In order to prove the presence of MSCs in our 
cells, we also showed expression of ALP (Alkaline Phosphatase) and Vimentin as 
previously shown (Prusa et al., 2003 and Fauza, 2004).  
In this study, in order to find out neurogenic differentiation capacity of HDFCs,   
firstly, it was shown that early neural markers Nestin and 3-Tubulin are being 
expressed by HDFCs and secondly,  some neuron-like cells were obtained by 
applying neural differentiation medium on HDFCs. Our data suggest for the first 
time that a retinoic acid mediated pathway might be triggered to induce neurogenic 
differentiation of HDFCs aiming to contribute to the literature by suggesting a 
potential molecular mechanism of neurogenic differentiation in HDFCs.
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2. MATERIALS AND METHODS
2.1 Materials
2.1.1 Dental Follicle Tissues:
Dental follicle tissue from a 17 years old patient was surgically removed with 
orthodontic reasons in Istanbul University School of Dental Medicine and was
sent to our laboratory in Yeditepe University, Department of Genetic and 
Bioengineering.
2.1.2 Cell Lines 
SH-SY5Y (Human metastatic neuroblastoma cell line) and HeLa (Human cervical 
cancer cell line) were kindly provided by Ömer Faruk Bayrak.
2.1.3 Tissue Culture
 Dulbecco’s Modified Eagle Medium (DMEM) 1g/liter glucose (Sigma)
 α-modified minimum essential medium (MEM) (Sigma)
 Fetal Bovine Serum (FBS) (Gibco)
 L-Glutamine solution (Gibco)
 Penicilin/Streptomycin/ Amphotericin (PSA) solution (Biological Industries, 
Israel)
 0,5% Trypsin-EDTA solution (Sigma)
 PBS (Gibco)
 T25 Tissue Culture Flasks (Nunc)
 T75 Tissue Culture Flasks (Nunc)
 T150 Tissue Culture Flasks (Nunc)
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 6-well culture plate (Nunc)
 Coverslip (Isolab)
 Steril scalpels
 Serological pipets,5 ml, 10 ml, 25 ml (Isolab)
 Centrifuge tubes, 15 ml (Falcon)
 Cryovials, 2 ml (Falcon)
2.1.4 Reverse Transcriptase and PCR (RT-PCR) Analysis
 Rneasy RNA isolation kit (Qiagen)
 Sensiscript Reverse transcriptase (Qiagen)
 Go taq flexi DNA polymerase (Promega)
 Oligo-dT (Sigma)
 RNAase inhibitor (Fermentas)
 dNTP Mix (Biogen)
 PCR Tubes
 Agarose (Sigma)
 Loading Buffer, 6x (Sigma)
 DNA Ladder (Sigma)
 TAE Buffer (Biobasic)
 Ethidium Bromide (Sigma)
2.1.5 Immunocytochemistry Analysis
 Paraformaldehyde (Sigma)
 Anti- human Trk-a antibody, mouse origin (Santa Cruz)
 Anti human β3-tubulin antibody , mouse origin (Santa Cruz)
 Anti human Osteocalcin antibody , mouse origin (Santa Cruz)
 Anti human NFM (Neuroflament Medium) , mouse origin (Santa Cruz)
 Anti human Oct-4 antibody , rabbit origin (Chemicon)
 Anti human NS antibody , rabbit origin (Chemicon)
 Triton X-100 (AppliChem)
 Goat polyclonal anti-rabbit IgG-Alexa 488 conjugate (Molecular Probes)
 Goat polyclonal anti-mouse IgG Alexa 488 cojugate (Molecular Probes)
 Goat polyclonal anti-rabbit IgG-Alexa 647 conjugate (Molecular Probes)
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 Goat polyclonal anti-mouse IgG-Alexa 647 conjugate (Molecular Probes)
 Leica TCS SP2 SE Confocal Microscope
 TO-PRO3 dye (Invitrogen)
 Mounting Medium (Mowiol)
2.1.6 Differentiation assays
 RANDOX Alkaline Phosphatase detection reagent (Randox Laboratories Ltd.)
 Von Kossa Staining Kit (Bio-Optica)
 Dexamethasone (Sigma)
 β-Glyserophosphate (Sigma)
 Ascorbate (Sigma)
 Ripa Buffer (Pierce)
 Polystyrene 96-well microplate (Orange Scientific)
 Elisa Plate Reader (Bio-Tek)
 Retinoic Acid (Sigma)
 Basic fibroblast growth factor (bFGF) (Sigma)
 Nerve Growth Factor (NGF) (Sigma)
 β-mercaptoethanol (AppliChem)
2.2 Methods
2.2.1 Cell Culture
2.2.1.1 Culture of HDFCs
Dental follicle used in this study was obtained from 17 years old patient whose  
impacted third molar germ (wisdom tooth) was surgically removed as a 
prophylactic treatment due to orthodontic reasons.  Written informed consent was 
obtained from the patient and his parents under approval of the local ethics 
committee of Istanbul University.
Dental follicle tissue was sliced into small pieces using sterile scalpels and plated 
on 6-well tissue culture plates in growth medium containing α-modified minimal 
essential medium (α-MEM) supplemented with 10% fetal bovine serum, 2 mM L-
glutamine (Biological Industries) and 1% PSA (penicillin, streptomycin and 
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amphotericin solution). The cells started to grow on the third day of incubation 
spreading from the tissue pieces and reached confluency in 4 days (Figure 3.1).
The cells were detached from dishes by incubating in trypsin-EDTA solution for 3 
minutes. After centrifugation at 1500 rpm for 5 minutes and resuspension in 
growth medium, cells were cultivated at 37 °C in a humidified atmosphere of 5% 
CO2 in T-75 flasks. The medium was changed every day and cell cultures were 
passaged every other day.
2.2.1.2 Culture of SH-SY5Y Cells
SH-SY5Y cell line was used in neurogenic differentiation experiments due to its 
neuronal origin as previousy reported. SH-SY5Y culture was maintained in 
DMEM containing 10% FBS, 2 mM L-Glutamine and 1% PSA solution. Cells were 
grown in T-75 flasks with 15 ml medium at 37ºC in 5% CO2 incubator until they 
reach to confluency. They were usually splitted every 2-3 days by tyripsinization.
2.2.2 Osteogenic Differentiation of HDFCs
HDFCs at passage 4 were used for osteogenic differentiation experiment. Cells 
were counted and cultivated in 6-well plates at 3000 cells/cm2 in growth medium. 
After 2 days, medium was shifted to osteogenic medium (a-MEM supplemented 
with 10% FBS, 0.1 mmol/l dexamethason, 10 mmol/l β-glycerophosphate, 50 mmol/l 
ascorbate). Osteogenic medium was changed every other day. All solutions were 
freshly prepared immediately prior to use (Protocol described by Delo and De 
Coppi, 2006).
2.2.3 Neurogenenic Differentiation
HDFCs and SH-SY5Y cells were seeded at a concentration of 3000 cells/cm2 in 6-
well plates. At the frist step, cells were incubated in α-MEM supplemented with 20% 
FBS, 0.1M Retinoic acid, 5 ng/ml basic fibroblast growth factor (bFGF) for 24 hours. 
At the second step, medium was shifted into α-MEM without serum, supplemented
with NGF (10ng/ml), and incubated 3 days by changing medium every day. All 
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solutions were freshly prepared immediately prior to use (Protocol described by 
Tatard et. al., 2007).
2.2.4 RT-PCR Analysis
Total RNAs were isolated from HDFCs at passage 4  and SH-SY5Y cells using 
RNeasy Mini Kit. First-strand cDNA synthesis was performed by using Sensiscript 
Reverse Transcriptase. Primer sets for each gene are listed in Table 2.1. PCR 
conditions were applied as reported in the literature Table 2.1. The amplified DNA 
fragments were visualized through 1.5% agarose gel electrophoresis, stained with 
ethidium bromide and photographed under UV light (Figure 3.2).
Table 2.1: Primers for PCR
Marker Sequence Length Ref.
Oct-4 forward: 5’-cgaccatctgccgctttgag-3’ 
reverse: 5’-ccccctgtcccccattccta-3’
572bp McLaughlin 
et al.,2006
NS forward: 5’-ggagtcctggatttccttcc-3’
reverse: 5’-gccctgaccactccagttta-3’
98bp Kafienah et. 
al.,2006
B3-Tubulin forward: 5’-ctcaggggcctttggacatc-3’
reverse: 5’-caggcagtcgcagttttcac-3’  
159bp Xao et.al., 
2001
Nestin forward: 5’-ggagtcctggatttccttcc-3’    
reverse: 5’-gccctgaccactccagttta-3’
200bp McLaughlin 
et al.,2006
B-actin forward:5’-gacaggatgcagaaggagattact-3’ 
reverse:5’ tgatccacatctgctggaaggt-3’
141bp Kafienah et. 
al.,2006
Osteocalcin forward;ggtgcaaagcccagcgactct-3’ 
reverse; ggaagccaatgtggtccgcta-3’
190bp Yoon 
et.al.2007
NFM forward: 5’ acg ctg gac tcg ctg ggc aa 3’
revers: 5’ gcg agc gcg ctg cgc ttg ta 3’
156bp Estus et.al. 
1997
hTERT forward: 5’-cctctgtgctgggcctggacgata-3’
revers: 3’-acggctggaggtctgtcaaggtag-3’
282bp Fujita et. 
al.,2005
ALP forward: 5’-gacatcgcctaccagctcat-3’
reverse:   5’-tcacgttgttcctgttcagc -3’
306bp Tare et. al. 
2005
Vimentin forward: 5’-tgaggctgccaaccggaaca-3’
reverse: 5’-ttggccgcctgcaggatgag-3’
208bp     Kameda et. 
al. 2003
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2.2.5 Immunocytochemistry Analysis
HDFCs and SH-SY5Y  cells were seeded on glass coverslips at 3000 cell/cm2 in 
6-well plates, cultured for 2 days and fixed with 2% paraformaldehyde (Appendix 
1, preparation of  2% paraformaldehyde). After rinsing with PBS, cells were 
permeabilized by incubating with 0.1 % Triton-X 100/PBS for 5 minutes. In order 
to avoid non-specific binding of antibodies, the cells were incubated with 2% FBS 
(diluted in PBS) for 20 min.  Samples were incubated with primary antibodies 
overnight at 4◦C. Each sample were washed twice for 5 minutes with PBS to 
remove unbound primary antibodies. After washing secondary antibodies were 
added and incubated  for 1 hour. For Oct-4 and NS  goat polyclonal anti-rabbit 
IgG-Alexa 488 conjugate was used. For NFM, β-3 Tubulin and Trk-A goat 
polyclonal anti- mouse IgG-Alexa 488 conjugate were used. TO-PRO3 dye 
(Invitrogen) was used to stain nuclei of the cells. Stained converlips were 
mounted on clean glass slides and fixed with Mowiol mounting medium
(Appendix 2). Prepared slides were observed under Confocal microscope (Leica 
TCS SP2 SE)  immediately after preparation in order to prevent fading.
2.2.6 ALP Activity
ALP activities of HDFCs were determined using RANDOX Alkaline Phosphatase 
detection reagent 500 µl of cold Ripa buffer was added on suspension of HDFCs 
(approximately 2.5x106 cells), pipetted well and centrifuged at 14.000 rpm for 15 
minutes to pellet the cell debris. Supernatant containing proteins were carefully 
transferred into a new 1ml plastic tube. Fifty microliter of supernatant  was mixed 
with 100µl of reagent in a 96-well plate and incubated at 37ºC for one and a half 
hours. 50µ of enzyme free water was mixed with 100µl of reagent in order to use as 
a reference. Absorbance of the wells was measured at 405 nm by an ELISA 
(Enzyme-Linked ImmunoSorbent Assay) plate reader at 15 minutes intervals.
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2.2.7 Von Kossa Staining 
After 8 days incubation with Osteogenic meidum in 6-well plates, the cells were 
fixed by incubating with 2% Paraformaldehyde at 4ºC for 30 minutes. After 
fixation cells were rinsed with distilled waster. Twenty drops Reagent A (Lithium 
carbonate saturated solution) was put on the cells and left to act for 10 minutes. 
Cell were rinsed with distilled water and 20 drops of reagent B (Silver nitrate 
solution) was put on the cells and left to act in dark for 1 hour. After incubation 20 
drops of reagents C (Reducing Solution), D (Sodium sulphate solution) and E 
(Mayer’s Carmalum) were put on the cells and left to act for 5 minutes 
respectively. After final rinsing 100% Ethanol was added and the sample were 
dehydrated. After drying the samples from the alcohol, the  cells were observed 
under light microscope.  
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3. RESULTS
3.1 Expansion of HDFCs
Dental follicle cells grew on culture dishes and showed fibroblast like morphology 
(Figure 3.1). It was observed that actively dividing cells contain sphere shape nuclei. 
When the thesis had been written, the 35th passage cultures were completed in 
Yeditepe University Cell Culture Laboratories. Undifferentiated HDFCs expanded 
extensively without feeder cells and doubled approximately every 36 hours.
  
Figure 3.1: Growing DFCs, (a) Cells spreading from tissue pieces; (b) Confluency on 
day 4.
3.2 RT-PCR analysis
RT-PCR analysis showed that HDFCs express Oct-4 and NS, Nestin, 3-tubulin,
hTERT (Figure 3.2), ALP and Vimentin (Figure 3.3). Prior to differentiation Ostecalcin 
and NFM expressions were not detectable but after osteogenic and neurogenic 
differentiation both of these proteins were expressed (Figure 3.3).  
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Figure 3.2: RT-PCR results before differentiation. (a) Oct-4, NS, β-actin, Nestin, β3-
Tubulin mRNAs were expressed; (b) Both HDFCs and HeLa cells expressed hTERT 
mRNA  
               
Figure 3.3: RT-PCR results after differentiation: (a) L:100 bp ladder, 1: ALP (306
bp), 2:Vimentin (208 bp), 3:Osteocalcin (190 bp); (b) L:100 bp ladder, 1: NFM 
expression in HDFCs , 2: NFM  expression in SH-SY5Y (156 bp) 
3.3 Immunocytochemistry analysis
In order to observe the localization of Oct-4, NS and 3-tubulin
immunocytochemistry experiment was carried out. Results demonstrated that Oct-4 
and NS expressions localize in the to the nuclei of the cells (Figure 3.4). While 
around 0.1% of the cells expressed Oct-4 protein,  95-99% of the cells expressed 
NS protein. Localization of 3-tubulin was shown in the cytoplasm of the cells. 
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Figure 3.4: Expression of (a)  Oct-4 (b) NS  and (c) B-3 tubulin.
In order to demonstrate osteogenic differentiation, HDFCs were analyzed for 
Collagen type I expression. Results revealed that HDFCs expressed Collagen type 
I. (Figure 3.5)
Figure 3.5. Collagen typeI immunocytochemistry staining of HDFCs (a) before 
osteogenic differentiation, (b) after osteogenic differentiation.
3.4 ALP Activity
ALP activity of HDFCs was determined by measuring the absorbance with an 
ELISA plate reader (Figure 3.6). 
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3.6: ALP activity of HDFCs: ALP activity was detected in the protein extracts 
derived from HDFCs. Graph shows that while absorbance of wells including protein 
extract of HDFCs increases by time due to activity of ALP, absorbance in reference 
wells remaines unchanged.
3.5 Von Kossa staining
After culturing HDFCs with osteogenic induction medium for 8 days, most of the 
cells showed the aggregates or nodules of calcium mineralization in the culture by 
von Kossa Staining. On the other hand HDFCs cultured in growth medium in this 
period did not show calcium mineralization (Figure 3.7).
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Figure 3.7 Osteogenic differentiation was demonstrated by von Kossa staining. 
(a) HDFCs cultured in osteogenic medium, (b) HDFCs cultured in growth 
medium. Blue arrows indicate aggregates of calcium mineralization.   
3.6 Neurogenic differentiation
To induce neural differentiation, HDFCs and SH-SY5Y cells were cultured in 
neurogenic medium including retinoic acid and bFGF at the first step and NGF at 
the second step. During 3- day incubation, cells changed their morphology 
producing neurites (axon-like extensions) (Figure 3.8). Induced HDFCs exhibited 
positive immunocytochemistry staining for neuron specific proteins, Trk-A, β-3 
Tubulin and NFM (Figure 3.9). 
  
Figure 3.8. Neuron-like cells with long axon-like structure
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Figure 3.9: Immunocytochemistry staining of Neuron-like cell. Expression of 
neurogenic markers after differentiation. SH-SY5Y cells were positively stained 
with (a) Trk-A, (b) NFM, and (c) β-3 Tubulin; HDFCs were positively stained with
(d) Trk-A (e) NFM, and (f) β-3 Tubulin 
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4. DISCUSSION
It has been reported that adult stem cells are not only found in bone marrow but 
also in a variety of tissues such as liver, nerve, muscle, skin, synovium, and 
cartilage (Spradling et. al. 2001; Gage, 2000). Bone marrow is one of the best 
potential sources of the mesenchymal stem cells (MSCs) and it is currently most 
preferred source to get large quantities of these stem cells. Despite this reputation, 
a surgical stress exists during isolation of stem cells from bone marrow. During the 
isolation of adult stem cells, reducing the surgical stress can be advantageous 
(Kose et. al.2003). Recent studies showed that extracted non-decayed impacted 
third molars, which are usually discarded, might be a very valuable source of these 
stem cells. Because dental follicles are being removed during standard prophylactic 
procedure and do not require additional surgical procedure. Utilization of such 
biological waste for the purpose of isolation of pluripotent stem cells present viable 
alternative to other sources. Isolation of MSCs-like stem cells from dental follicle of 
impacted third molars was successfully performed by different groups (Morsczeck 
et. al. 2005). Stem cells isolated from the extracted third molars showed in vitro/in 
vivo osteogenic differentiation (Morsczeck et. al. 2005). Investigation of pluripotency 
potential of dental follicle cells isolated from impacted third molars requires analysis 
of Oct-4 expression. NS expression indicates that HDFCs are actively dividing and 
proliferating cells. 
In this research, HDFCs were successfully isolated from non-decayed impacted 
third molar of a 17 years old patient. There are several advantages of isolating 
HDFCs. First, it does not interfere with patient’s orthodontic treatment. Secondly, it 
does not raise any ethical issues that are associated with human embryonic stem 
cell research. Thirdly, it is a potential source of MSCs which might be used in 
autologous transplantation without inducing tissue rejection.
Our results are consistent with the recent reports which demonstrated the presence 
of undifferentiated multipotent stem cells in dental follicles (Yao et. al. 2004). There 
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are also evidences that Oct-4 is expressed by cranio facial stem cells such as 
dental pulp, suggesting that there might be pluripotent stem cells in dental tissues 
(Huang, et. al. 2008). So far, there has been no report showing expression of Oct-4 
and NS in dental follicle derived cells. To investigate if there are Oct-4 and NS 
expressing cells in HDFCs, we performed RT-PCR and immunocytochemistry 
analysis. 
RT-PCR results showed that Oct-4 and NS mRNAs were expressed by HDFCs. 
Immunocytochemistry analysis also showed the existence and  localizations of 
these two proteins  in the nucleus. The number of Oct-4 expressing cell is very 
important in order to understand exact pluripotent stem cell capacity of HDFCs. 
During the analysis, the number of Oct-4 positive cells was less than 1% suggesting 
that it might  be very difficult to detect and isolate Oct-4 expressing pluripotent stem 
cells from dental follicles. It has been reported that during  the cultivation, 
spontaneously differentiating cells, by secreting some cytokines, cause the 
reduction of pluripotency of the stem cells in the population.  pluripotent stem cells 
loose their pluripotency (Fauza, 2004). Therefore if the pluripotent cells are not 
isolated from the rest of the cells in very early passages, they might gain the 
characteristics of general population in the cell culture. Surface antigens can be 
utilized in this case. For example, c-kit (CD117, stem cell factor receptor) 
expressing cells were isolated from amniotic fluid samples, which contains 0-1% 
pluripotent stem cells (Fauza, 2004), and can cultivated in different culture 
conditions. These isolated pluripotent stem cells differentiated into all cell types 
coming from three embryonic germ layers (ectoderm, mesoderm and endoderm) 
(De Coppi et. al. 2007). Therefore, small number of Oct-4 expressing cells in 
HDFCs might be isolated by utilizing their surface antigens such as c-kit in magnetic 
separation systems. On the other hand, the majority of cells (90-95%) expressed 
NS proteins like stromal stem cells in human bone marrow (Kafienah, 2006). This 
means that although most of the cells are proliferative and actively dividing, majority 
of them are not pluripotent. Isolation of these rare pluripotent stem cells and their 
enrichment might provide researchers with an alternative source of pluripotent stem 
cells for tissue engineering and cell therapy applications.
There has been increased interest in studies of reprogramming the somatic cells to 
yield pluripotent stem cells received attention. By transfecting somatic cells with 
transcription factors, Oct-4, Sox2, cMyc, and Klf4, the mouse cells were 
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successfully reprogrammed producing induced pluripotent stem cells (iPS) without 
going through a nuclear transfer into the eggs (Takahashi et. al. 2006) (Figure 4.1)
Figure 4.1: Generation of iPS cells
Application of this process in human therapy seems very exciting but there are still 
many questions to be answered. A major question is: Are these cells really exact 
counterparts of normal pluripotent stem cells? Usage of Oct-4 expressing 
pluripotent stem cells that already exist in adult tissues might be a safer strategy 
than generating iPS cells using extensive genetic manipulations.  
Telomerase is required for the maintenance of stable telomere length in replicating 
cells (Greider et.al.1989). In this study, HDFCs showed telomerase activity 
suggesting that they protect their telomeres as they undergo cell division (Figure 
3.2).  ALP expression is also found in undifferentiated stem cells (Prusa et. al. 
2003). During osteogenic differentiation, while ALP expression decreases, 
Osteocalcin expression elevates (Park et.al., 2007). HDFCs showed ALP activity
(Figure3.6) but did not express osteocalcin before osteogenic induction. These data 
indicate that stem cells isolated from HDFCs are undifferentiated.
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Previous studies showed that HDFCs have capacity to differentiate into osteocytes 
(Lindroos et. al., 2008). In this study it was also demonstrated HDFCs isolated from 
non decayed impacted third molar are able to differentiate into osteocytes. After 
osteogenic induction, HDFCs formed aggregates of calcium mineralization and 
expressed bone specific collagen type I (Figure 3.5 and Figure 3.7). This data 
proved that multipotent stem cells were successfully isolated from HDFCs. 
Many studies investigated for a long time if adult stem cells can transdifferentiate, 
e.g. if a hematopoietic stem cell give rise to a muscle cell or a neuron instead of 
blastocytes or leukocytes. So far, there is promising evidence that some of the adult 
stem cells have transdifferentiation potential (Ho et al. 2005). Neurotrophic factors 
regulate survival, differentiation, growth and plasticity in the nervous system. 
Neurotrophic factors are expressed in developing dental tissues (Yamazaki et. al. 
2007). Most recently, It has been reported that neuron like cells can be isolated 
from peridontium (Widera et. al. 2007). Also precursor cells derived from human 
dental follicle express neuroflament, map2 and β-3 tubulin expressions (Völlner et. 
al. 2007). Our results are consistent with previous data suggesting that HDFCs can 
differentiate into neurons. In this study a retinoic acid mediated neurogenic 
differentiation model were suggested for HDFCs. In this model, SH-SY5Y cells were 
used as positive control as they can show neurogenic differentiation in the presence 
of retinoic acid. Retinoic acid causes the cells to stop dividing and express Trk 
receptor which recognize NGF and Neurotrophin molecules (Kou et al. 2008). In this 
neurogenic differentiation experiments it was found that Trk-A and NFM proteins are 
expressed by both HDFCs and SH-SY5Y cells upon induction with Retinoic acid 
and NGF (Figure 3.9). After three days of incubation, NFM expressing cells were 
identified in both cell cultures by immunocytochemistry. RT-PCR data also showed 
that differentiated cells expressed NFM mRNA (Figure 3.3). Data shown in this 
experiment supports the evidences that HDF derived stem cells might be a readily 
accessible autologous stem cell source for therapeutic research in neuroscience. 
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5. CONCLUSION
In recent years, many technical and ethical problems in the clinical applications of 
ESC forced the scientists for searching new, novel and/or alternative adult stem 
sources and their characterization. Human dental follicle is one of this highly 
proliferative stem cell sources and It is easy obtain as a product of extracted teeth 
(Morsczeck et. al., 2005).  Especially non-decayed impacted third molars contain 
stem cells without any infection. So far, the studies characterizing HDFCs have 
revealed that important marker proteins such as ALP, Vimentin, and Nestin are 
expressed by HDFCs. However, there was no study analyzing expression of Oct-4 
and NS, which are markers of pluripotent stem cells, in HDFCs. By performing both 
RT-PCR experiment and immunocytochemistry it was proved that proved that these 
markers are being expressed together in a very small population of cells. As Oct-4 
is a key regulator of differentiation, this small population of cells is of great 
significance. Isolation and enrichment of Oct-4 expressing pluripotent stem cells 
from HDFCs might provide us stem cells source having capacity to differentiate into 
all three embryonic germ layer cells. Full characterization of HDFCs will enable us 
an alternative source to bone marrow in autologous transplantations. 
In consistent with the previous data suggesting neurogenic potential of HDFCs, it 
was shown in this study that HDFCs are expressing some early neural markers 
such as Nestin and β3-Tubulin. In addition to this, it was also tested if a retinoic acid 
mediated neurogenesis might be triggered in HDFCs. Eventually, it was obtained 
that in the presence of retinoic acid and NGF, HDFCs gave rise to neuron-like cells 
expressing some mature neuron markers. Depending on these studies it can be 
hypothesized that HDFCs derived from human wisdom teeth represent a rational 
source for stem cells capable of differentiation into osteocytes and neurons. 
38
REFERENCES
Bartold, P.M., Shi, S.,Gronthos, S.,2000., Stem cells and periodontal 
regeneration, Periodontology 2000, Vol. 40, 2006, 164–172
Beattie GM, Otonkoski T, Lopez AD, Hayek A, 1997, Functional beta-cell mass 
after transplantation of human fetal pancreatic cells: differentiation or 
proliferation? Diabetes. 46(2):244-8.
Bianco P, Riminucci M., 1998, The bone marrow stroma in vivo: Ontogeny, 
structure, cellular composition and changes in disease. In Marrow 
Stromal Cell Culture. Handbooks in Practical Animal Cell Biology, ed. 
J.N. Beresford and M.E. Owen, p. 1025. Cambridge, UK: Cambridge 
University Press.
Bittner, R.E., Schofer, C., Weipoltshammer, K., Ivanova, S., Streubel, B., 
Hauser, E., Freilinger, M., Hoger, H., Elbe-Burger, A., and 
Wacthler, F. ,1999,  Recruitment of bone-marrow-derived cells by 
skeletal and cardiac muscle in adult dystrophic mdx mice. Anat 
Embryol (Berl) 199:391-6.
Bongso, A. and Lee E.H., 2005  Stem Cells: Their definition, Classification and 
Sources, in Stem cells  from bench to bedside pp.1-13, World 
Scientific Publishing Co. Singapore.
Bongso, A., Richards, M., and Fong, C.Y., 2005, From Human Embryos to 
Clinically Compliant Embryonic Stem Cells: Blastocyst Culture, Xeno-
free Derivation and Cryopreservation, Properties and Applications of 
Embryonic Stem Cells, in Stem cells  from bench to bedside pp. 14-
38, World Scientific Publishing Co. Pte. Ltd. Singapore
39
Brazelton, T.R., Rossi, F.M., Keshet, G.I., and Blau, H.M., 2000, From marrow to 
brain: expression of neuronal phenotypes in adult mice. Science
290:1775-9.
Brustle, O., Choudhary, K., Karram, K., Huttner, A., Murray, K., Dubois, D.M., 
and McKay, R.D., 1998, Chimeric brains generated by 
intraventricular transplantation of human brain cells into embryonic 
rats. Nat Biotechnol 16 (11):1040-4.
Caplan AI (2000). Mesenchymal stem cells and gene therapy. Clin Orthop Rel Res 
379 (Suppl.): S67–S70.
Caplan AI. ,1994, The mesengenic process. Clin Plast Surg 21: 429–435.
Chen, S., Santos, L., Wu, Y., Vuong, R., Gay, I., Schulze, J., Chuang, H. H., and 
MacDougall, M., 2005, Altered gene expression in human 
cleidocranial dysplasia dental pulp cells., Arch. Oral Biol. 50, 227–
236.
Coppi, P.D., Bartsch, G., Siddiqui, M.M., Xu T., Santos, C.C., Perin L., 
Mostoslavsky, G., Serre,A.C., Snyder, E.Y., Yoo J.J., Furth M.E., 
Soker S., Atala, A., 2007, Isolation of amniotic stem cell lines with 
potential for therapy, Nature Biotechnology 25, 100 –106.
Delo D.M., De Coppi, P., Bartsch, G. J., Atala, A., 2006, Amniotic fluid and 
placental stem cells, Methods in Enzymology, 419:426-38
Draper, J.S., Smith, K., Gokhale, P., Moore, H.D., Maltby, E., Johnson, J.,  
Meisner, L., Zwaka, T.P., Thomson, J.A., Andrews, P.W., 2003, 
Recurrent gain of chromosomes 17q and 12 in cultured human 
embryonic stem cells, Nature Biotechnology 22, 53 – 54
Eglitis, M. A., and Mezey, E., 1997, Hematopoietic cells differentiate into both 
microglia and macroglia in the brains of adult mice, Proc. Natl. Acad. 
Sci. USA Vol. 94, pp. 4080-4085
Estus S., Tucker H.M., Rooyen C.V., Wright S., Brigham E.F., Wogulis M. ,1997, 
Aggregated Amyloid-ß Protein Induces Cortical Neuronal Apoptosis 
40
and Concomitant "Apoptotic" Pattern of Gene Induction. J Neurosci  
17: 7736-45.
Fang, T.C., Alison, M.R.,Wright, N.A.,Poulsom, R., 2004 Adult stem cell plasticity: 
will engineered tissues be rejected? International Journal of 
Experimental Pathology 85 (3) , 115–124
Fauza D., 2004, Amniotic fluid and placental stem cells, Best Practice & Research 
Clinical Obstetrics and Gynaecology Vol. 18, No. 6, pp. 877–891
Ferrari, G., Cusella, G., Angelis D., Coletta, M., Paolucci, E., Stornaiuolo, A.,  
Cossu, G., Mavilio., F, 1998, Muscle Regeneration by Bone 
Marrow-Derived Myogenic Progenitors, Science Vol. 279. no. 5356, 
pp. 1528 – 1530
Fujita T., Tanaka Y.O., Tahara H., Ide T., Abiko Y., Mega J., 2005  Establishment 
of immortalized clonal cell derived from preidontal ligament cells by 
induction of the hTERT gene.  J. Oral Science; vol.47-4:177-184
Gage FH. 2000, Mammalian neural stem cells. Science; 287: 1433-38.
Greider CW, Blackburn EH., 1989, A telomeric sequence in the RNA of 
Tetrahymena telomerase required for telomere repeat synthesis. 
Nature;  337: 331-7.
Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., and Shi, S. 2000, Postnatal 
human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. 
Acad. Sci. USA 97, 13625–13630.
Hidetoshi Yamazaki, H., Tsuneto. M., Yoshino. M.,Yamamura, K.I., Hayashi, 
S.I., 2007, Potential of Dental Mesenchymal Cells in Developing 
Teeth, Stem Cells Vol. 25 -1 pp. 78-87
Ho, A.D. and Wagner, W., 2003. Clinical Potentials of Stem Cells: Hype or Hope?in 
Stem Cell transplantation, pp. 3-25 WILEY-VCH Verlag GmbH & Co. 
KGaA, Weinheim.
41
Huang A.H.C., Chen, Y.K., Lin,L.M., Shieh, T.Y.,Chan, A.W.S., 2008, Isolation 
and characterization of dental pulp stem cells from a supernumerary 
tooth, J Oral Pathol Med, (Epub ahead of print)
Humpherys, D., Eggan, K., Akutsu, H., Hochedlinger K., Rideout, W.M., 
Biniszkiewicz,D., Yanagimachi, R., Jaenisch R., 2001, Epigenetic 
Instability in ES Cells and Cloned Mice, Science, vol. 293. no. 5527,
pp. 95 – 97
Ikeda E, Hirose M, Kotobuki N, Shimaoka H, Tadokoro M, Maeda M, Hayashi H, 
Kirita T, Ohgushi H, et al. 2006.Osteogenic differentiation of human 
dental papilla mesenchymal cells. Biochem Biophys Res Commun; 
342: 1257-62.
J. Kim,J., Lee,Y.,  Kim, H.,  Hwang, K. J., Kwon, H. C.,  Kim, S. K.,  Cho, D. J., 
Kangand S. G., You, J., 2007, Human amniotic fluid-derived stem 
cells have characteristics of multipotent stem cells, Cell Proliferation
40 (1) , 75–90
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., 
Ortiz‐Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, 
M., Du, J., Aldrich, S., Lisberg, A., Low, W. C.,Largaespada, D. 
A., and Verfaillie, C. M. 2002, Pluripotency of mesenchymal stem 
cells derived from adult marrow. Nature 418, 41–49.
JS Odorico, DS Kaufman, JA Thomson, 2001, Multilineage Differentiation from 
Human Embryonic Stem Cell Lines, Stem Cells, Vol. 19, No. 3, 193-
204
Kafienah W, Mistry S, Williams C, Hollander AP, 2006, Nucleostemin is a marker 
of proliferating stromal stem cells in adult human bone marrow, Stem 
Cells.; 24: 1113-20.
Kakishita K, Nakao N, Sakuragawa N and Itakura T, 2003, Implantation of  
human amniotic epithelial cells prevents the degeneration of nigral 
dopamine neurons in rats with 6-hydroxydopamine lesions, Brain 
Res 980,48-56.
42
Kameda, Y., Arai, Y., Nishimaki, T., 2003, Ultrastructural localization of vimentin 
immunoreactivity and gene expression in tanycytes and their 
alterations in hamsters kept under different photoperiods, Cell Tissue 
Res 314:251–262
Kogler ,G., Radke, T., Lefort, A., Sensken, S., Fischer, J., Sorg R.V., Wernet, P.
2005, Cytokine production and hematopoiesis supporting activity of 
cord blood derived unrestricted somatic stem cells. Exp Hematol,  33, 
573–583.
Kose GT, Korkusuz F, Korkusuz P, Purali N, Ozkul A, and Hasırcı V. 2003, 
Bone generation on PHBV matrices: an in vitro study. Biomaterials; 
24: 4999-5007.
Kou,W.,  Luchtman, D., Song., C, 2008, Eicosapentaenoic acid (EPA) increases 
cell viability and expression of neurotrophin receptors in retinoic acid 
and brain-derived neurotrophic factor differentiated SH-SY5Y cells 
Eur J Nutr ,47:104–113
Lagasse, E., Connors, H., Al-Dhalimy, M., Reitsma, M., Dohse, M., Osborne, L., 
Wang, X., Finegold, M., Weissman, I.L., and Grompe, M. 2000, 
Purified hematopoietic stem cells can differentiate into hepatocytes in 
vivo, Nat Med 6:1229-34.
Lindroos, B., Katja Maenpaa, K., Ylikomi, T., Oja, H.,Suuronen, R., Miettinen, 
S., 2008, Characterisation of human dental stem cells and buccal 
mucosa fibroblasts, Biochemical and Biophysical Research 
Communications, 368(2):329-35 
Liu, H., Li, W., Shi, S., Habelitz, S., Gao, C., and Denbesten, P., 2005, MEPE is 
downregulated as dental pulp stem cells differentiate. Arch. Oral Biol. 
50, 923–928.
McLaughlin D, Tsirimonaki E, Vallianatos G, Sakellaridis N, Chatzistamatiou T, 
Stavropoulos-Gioka C et al., 2006. Stable expression of a neuronal 
dopaminergic progenitor phenotype in cell lines derived from human 
amniotic fluid cells, J Neurosci Res.; 83: 1190-200.
43
Morsczeck C, Gotz W, Schierholz J, Zeilhofer F, Kuhn U, Mohl C, et al., 2005,
Isolation of precursor cells (PCs) from human dental follicle of 
wisdom teeth Matrix Biol; 24: 155-65
N Levicar , 2007, Adult Stem Cells as a Treatment for Liver Diseases in Stem Cell 
Repair And Regeneration, Nagy A Habib, Natasa Levicar, Myrtle Y 
Gordon Long Jiao, Nicholas Fisk pp.125-138 Imperial College 
Press, London.
National Academy of Sciences, 2001, Stem Cells and the future of regenerative 
medicine, pp. 19-29, National Academy Press,Washington, D.C.
Negrin, R.S., Atkinson, K., Leemhuis, T., Hanania, E., Juttner, C., Tierney, K., 
Hu, W.W., Johnston, L.J., Shizuru J.A., Stockerl-Goldstein, K.E., 
Blume, K.G., Weissman, I.L., Bower S., Baynes, R.,Dansey, R., 
Karanes, C., Peters, W., and Klein, J., 2000, Transplantation of 
highly purified CD32+Thy-1+ hematopoietic stem cells in patients 
with metastatic breast cancer. Biol Blood Marrow Transpl 6:262-71.
Pan GJ, Chang ZY,Er H.R.S, Pei D. et al., 2002, Stem cell pluripotency and 
transcription factor Oct-4, Cell Res; 12: 321-329.
Park BW, Hah YS, Kim DR, Kim JR, Byun JH., 2007, Osteogenic phenotypes and 
mineralization of cultured human periosteal-derived cells, Arch Oral 
Biol; 52: 983-9.
Pera M.F., 2004,Unnatural selection of cultured human ES cells? Nature Biotech 
22:42–43.
Pera, M.F., Dottori, M., 2005, Transcriptome Profiling of Embryonic Stem Cells, in 
Stem cells  from bench to bedside, pp.55-71 Ariff Bongso & Eng Hin 
Lee. , World Scientific Publishing Co. Pte. Ltd. Singapore
Petersen, B. E., Bowen, W. C., Patrene, K. D.,  Mars, W. M.,  Sullivan, A. K.., 
Murase, N., Boggs, S. S.,  Greenberger, J. S., Goff  J. P., 1999, 
Bone Marrow as a Potential Source of Hepatic Oval Cells, Science 
Vol. 284. no. 5417, pp. 1168 – 1170
44
Prusa A.R.,, Marton, E., Rosner, M.,  Bernaschek, G., and Hengstschläger. M.,
2003, Oct-4-expressing cells in human amniotic fluid: a new source 
for stem cell research? Human Reproduction, Vol. 18, No. 7, 1489-
1493
Qi, H., Pei, D., 2007, The magic of four: induction of pluripotent stem cells from 
somatic cells by Oct4, Sox2, Myc and Klf4, Cell Research 17:578-
580.
Raff M., 2003, Adult stem cell plasticity: fact or artifact? Annu.Rev. Cell. Biol.19:1-
22
Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S, Brahim J, et al. 2004, 
Investigation of multipotent postnatal stem cells from human 
periodontal ligament. Lancet; 364: 149-55
Spradling, A., Drummond-Barbosa, D., Kai, T., 2001. Stem cells find their niche,
Nature;414:98-104.
Szilvassy, S.J., Meyerrose, T.E., Ragland, P.L., Grimes,B., 2001, Differential 
homing and engraftment properties of hematopoietic progenitor cells 
from murine bone marrow, mobilized peripheral blood, and fetal liver,
Blood,  98, 2108–2115.
Tai MH, Chang  CC, Olson  LK, Trosko JE. 2005. Oct4 expression in adult human 
stem cells: evidence in support of the stem cell theory 
carcinogenesis, Carcinogenesis vol.26 no.2 pp.495-502
Takahashi K, Yamanaka S., 2006, Induction of pluripotent stem cells from mouse 
embryonic and adult fibroblast cultures by defined factors. Cell  ; 126: 
663-76.
Tanaka,S., Matsuzaka,K., Sato, D., Inoue,T., 2007, Characteristics of Newly 
Formed Bone During Guided Bone Regeneration: Analysis of cbfa-1, 
Osteocalcin, and VEGF Expression Journal of Oral Implantology  33 : 
321-326
Tare, R.S., Howard, D., Pound, J. C., Roach, H.I., Oreffo, R.C., 2005, Tissue 
engineering strategies for cartilage generation Micromass and three 
45
dimensional cultures using human chondrocytes and a continuous 
cell line, Biochemical and Biophysical Research Communications
Volume 333- 2: 609-621
Tatard, V.M., Dippolito, G., Diabria, S.,Valeyev, A., Hackman, J., McCarthy, M., 
Bouckenooghe,T., Menei, P., Menei, C.N., Schiller, P.C., 2007, 
Neurotrophin-directed differentiation of human adult marrow stromal 
cells to dopaminergic-like neurons, Bone, 40:360-373 
Tsai M.S., Lee, J.J., Chang Y.J., Hwang S.M., 2004, Isolation of human 
multipotent mesenchymal stem cells from second-trimester amniotic 
fluid using a novel two-stage culture protocol. Human Reproduction
Vol.19, No.6 pp. 1450-1456
Völlner, F., Driemel, O., Reichert, T.E., Morsczeck, C, 2007, Differentiation and 
Characterization of Dental Follicle Precursor cells (PCs), European 
Cells and Materials Vol. 14. Suppl. 2, 2007
Wagers, A.J., Christensen, J.L., Weissman, I.L., 2002, Cell fate determination 
from stem cells. Gene Therapy 9: 606–612.
Widera, D., Grim, W.D., Moebius, J.M., Mikenberg, I., Czek, C.P, Gassman G, 
Wolf N.A., Thevenod, F., Kaltschmidt, C., and Kaltschmidt 2007, 
Highly efficient neural differentiation of Human Somatic Stem Cells, 
isolated by minimaly invasive periodontal surgery, Stem Cell and 
Development 16:447-460
Xiao Z.S., Quarles L.D., Chen Q.Q., Hui Yu Y., Ping Qu X, Jiang C.H. Deng 
H.W., Li, Y.J., Zhou, H.H., et. al., 2001., Effect of asymmetric 
dimethylarginine on osteoblastic differentiation. Kidney Int; 60: 1699–
704.
Yamazaki,H., Tsuneto, M., Yoshino, M., Yamamura, K.I.  and Hayashi, S.I.,
2007, Potential of Dental Mesenchymal Cells in Developing Teeth, 
Stem Cells,25,78-87
Yao S, Norton J, Wise, G.E., 2004, Stability of cultured dental follicle cells. Cell 
Prolif; 37: 247-54.
46
Yoon, S.Y., Park, K.S., Choi, B.S., Khang G., Kim, M.S.,Rhee, J.M., Lee, H.B., 
2007, Effect of DBP/PLGA Hybrid Scaffold on Angiogenesis during 
the Repair of Calvarial Bone Defect, Key Engineering Materials Vols. 
342-343:161-164
Zhu Q, Yasumoto H, Tsai, R.Y., 2006, Nucleostemin delays cellular senescence 
and negatively regulates TRF1 protein stability. Mol Cell Biol.; 26: 
9279-90.
URL-1:
<http://www.umdnj.edu/gsbsnweb/stemcell/scofthemonth/scofthemonth2/embryonic
germcell/1.jpg , accessed at 23.04.2008.
URL-2:
<http://www.earthbornwellness.com/images/StemFigure3_sml.jpg>, accessed at 
23.04.2008.
47
APPENDICES
Appendix 1. Preparation of 2% Paraformaldehyde
Preparation of a paraformaldehyde fixative solution
Reagent grade paraformaldehyde powder  (Sigma). For  10ml of a 4% 
paraformaldehyde stock solution:
       
1. Weigh out 0.4 g of paraformaldehyde, transfer powder into 15 ml conical 
tube (Falcon).
2. Add  8 ml of ddH2O
3. Add  5 µl of 1M NaOH
4. Heat  to 70˚C (cap on), mix frequently until complete solubilization  (-10 min 
at 70˚C; the solution should become clear)
5. Put on ice and allow the solution to cool down to room temperature
6. Adjust  volume  to 9 ml with ddH2O
7. Add 1 ml of PBS 10X and mix.
8. Filter solution using a 0.2 µm 25 mm nylon syringe filter.
9. Prepare  a 2% paraformaldhyde solution by diluting 4% paraformaldhyde 
solution in PBS.
       Use  the fixative  at room temperature
Appendix 2. Preparation of Mowiol Mounting medium
Mowiol is a brand-name of polyvinyl  alcohol solution. It hardens to match the 
refractive index  of immersion oil, so it has gained a reputation for being a good 
mounting medium  to use on fixed  cells that are to be viewed with epifluorescence  
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or  Confocal microscopes. Most users add an additioal antifade reagent to retard 
photobleaching.
Mowiol 4-88 can be purchased from EMD Biosciences and  Polysciences .There 
are many recipes  for Mowiol mountants out there—the one below is from the 
Research Technologies Branch of the NIAID/NIH.
1. Put 6 g of glycerol in a plastic 50 mL centrifuge tube, along with  a small stir 
bar.
2. Add 2.4 g Mowiol  4-88; stir to mix.
3. While stirring, add 6 mL distilled water, leave stirring at room temperature 
for 2 hours.
4. Add 12 mL 0.2 M Tris, Ph 8.5. If  desired, add sodium azide to a final 
concentration of  0.02%.
5. Incubate  the tube in hot water  (50-60˚C ) for -10 minutes to dissolve the 
Mowiol.
6. Add anti-fade reagent (optional).
7. Centrifuge at 5000 g for 15 minutes to remove any undissolved  solids.
8. Store 1 mL aliquots in Eppendorf tubes at -20˚C .
9. To use, warm to room temperature. Opened tubes can be stored at 4˚C for 
approximately 1 month. Discard if you see crystalline  material  in the tube 
or  on your slides.
You  should only use about 15-20 µl of this for 22 x 22 mm coverslip,or 40-50µ  for 
a 22 x 50 mm coverslip. Leave your coverslipped  slides in the dark overnight to 
harden before using an oil or water immersion microscope objective.
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